Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

California Governor Vetoes Bill that Proposed to Increase Regulation of Private Equity Investments in Health Care

By Jeremy Alexander & Andrew J. Sylora on October 2, 2024
Email this postTweet this postLike this postShare this post on LinkedIn

On September 28, 2024, California governor Gavin Newsom vetoed AB 3129, a bill that, among other things, would have required private equity firms and hedge funds to provide 90 days’ prior written notice to, and for some transactions, obtain consent from, the state attorney general prior to proceeding with certain health care transactions.

In a statement attached to his decision to veto AB 3129, the governor cited concerns regarding the redundancy of the bill given that under current law the state’s Office of Health Care Affordability (OHCA) is responsible for analyzing and evaluating certain health care consolidation transactions. While OHCA does not have the power to block a covered transaction, OHCA may refer to and coordinate with the state’s attorney general to review any transactions that may be anti-competitive or affect health care affordability.

In light of the recent increase in federal and state scrutiny of private equity investments in health care about which we have previously written, we will continue to monitor regulatory developments in this area.

If you have any questions about this article, please contact Jeremy M. Alexander at jmalexander@vedderprice.com or the Vedder Price attorney with whom you normally work.

Photo of Jeremy Alexander Jeremy Alexander

Jeremy M. Alexander is a Shareholder in Vedder Price’s Washington, DC office and Chair of the Health Care & Life Sciences practice group. Mr. Alexander focuses his practice on managing intricate regulatory, transactional and enforcement issues for health care providers and suppliers.

Read more about Jeremy AlexanderEmail
Photo of Andrew J. Sylora Andrew J. Sylora

Andrew J. Sylora is an Associate in Vedder Price’s Chicago office and a member of the firm’s Health Care & Life Sciences practice group. Mr. Sylora focuses his practice on advising clients in the life sciences and health care industries on a wide…

Andrew J. Sylora is an Associate in Vedder Price’s Chicago office and a member of the firm’s Health Care & Life Sciences practice group. Mr. Sylora focuses his practice on advising clients in the life sciences and health care industries on a wide range of transactional, regulatory and compliance matters.

Read more about Andrew J. SyloraEmail
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Federal Regulatory & Enforcement Insider
  • Organization:
    Vedder Price PC
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo